Canadian Internet Rx drug exports crash

1 April 2007

A study by IMS Health has found that exports of prescription drugs from Canada sold via the Internet to US residents fell almost 50% last year (Marketletter March 23), the Canadian Press reports. However, a spokesman for the drug industry research group noted that changes in US legislation to allow licensed pharmacists to send drugs to the USA could rapidly change the trend.

The US Congress has been debating proposed reforms that would allow Canadian Internet pharmacies to be licensed by the US Food and Drug Administration and to sell prescription drugs on-line (Marketletter January 22).

Ian Therriault, an IMS Health spokesman, told the Canadian Press that a strong exchange rate versus the US dollar and the expansion of Medicare prescription drug coverage under the Part D program (Marketletters passim) provide economic reasons for the dramatic fall in Canadian drug sales to the USA. Another factor that went unreported is likely to have been the price war between US retailers, including the world's largest, Wal-Mart, in the generic drug market, where prices are generally lower than in Canada (Marketletters passim).

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK







Today's issue

Company Spotlight